Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
Pfizer
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Wake Forest University Health Sciences
Revolution Medicines, Inc.
Mayo Clinic
Brigham and Women's Hospital
Mayo Clinic
University of Kentucky
Tempus AI
Swiss Cancer Institute
AstraZeneca
BeiGene
Incyte Corporation
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
Bank of Cyprus Oncology Centre
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
NanOlogy, LLC
SWOG Cancer Research Network
ImmunoGenesis
Instituto Nacional de Cancerologia de Mexico
University of Kentucky
Faeth Therapeutics
Yale University
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Alethia Biotherapeutics
Elevation Oncology
Fundación GECP
Spanish Lung Cancer Group
University of Texas Southwestern Medical Center
EpicentRx, Inc.
Radiation Therapy Oncology Group
Hoosier Cancer Research Network
University of Pittsburgh
OncoNano Medicine, Inc.
AstraZeneca
Vergent Bioscience, Inc.
Sun Yat-sen University
Celgene
Case Comprehensive Cancer Center
SWOG Cancer Research Network